Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Morris, M.D.
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
539 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- the Vitalite Health Network - Dr Leon Richard Oncology Centre
Moncton, New Brunswick, Canada
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Doctor H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Cambridge Memorial Hospital
Cambridge, Ontario, Canada
- Grand River Regional Cancer Centre at Grand River Hospital
Kitchener, Ontario, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Fundacion de Investigacion de Diego
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Veterans Affairs Medical Center
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Southern Cancer Center Pc-Providence
Mobile, Alabama, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Fowler Family Center for Cancer Care
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Veteran'S Administration Medical Center
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Hospital
Fontana, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- California Cancer Center - North Fresno
Fresno, California, United States
- Kaiser Permanente
Fresno, California, United States
- University Oncology Associates
Fresno, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jan 2014
- Primary completion
- 2 Nov 2018
- Completion
- 31 Aug 2024
- Last update posted
- 28 Sept 2023
- Registered enrollment
- 1,311
- Registry id
- NCT01949337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.